You are now leaving this website.
Are you sure?
  1. CORPORATE - 23-01-2017

    BIVIGAM® will no longer be available for sale or distribution in 2017

    Distribution agreement between Biotest and Kedrion Biopharma has been terminated

    read more 
  2. CORPORATE - 18-01-2017

    KEDPLASMA Advances Long-Range Growth Plan

    KEDPLASMA acquires 2 FDA-licensed and EU-certified plasma collection centers from IMMUNOTEK

    read more 
  3. EVENTS - 19-12-2016

    Kedrion Biopharma attends ASHP 2016 midyear clinical meeting

    Kedrion Biopharma has recognized the changing role of pharmacists in the decision-making process

    read more 
  4. CORPORATE - 07-11-2016

    Kedrion Biopharma and Kamada Announce FDA Acceptance of BLA Submission for Human Rabies Immunoglobulin as a Post-Exposure Treatment

    FDA has accepted for review a BLA for a human anti-rabies immunoglobulin (IgG) therapy

    read more 


For more information please contact: